CNS Pharmaceuticals Inc. (NASDAQ:CNSP) changes shares on Tuesday trading session, with a change of 5.46% or $0.1 shares. The trading starts at $1.90 and closed at $1.83 throughout the day. The trading session low price was $1.88 and day high was $1.9773 on Tuesday, August 04. After the session, the Healthcare sector daily volume shifted to 34116.0 while its average volume is 93.30K. In other hand, the CNSP market cap reached to $32.27M.
On June 30, 2020, BRIEF-CNS Pharmaceuticals Engages Berry Consultants To Advise Phase 2 Trial Design. According to the news reported on Reuters, * CNS PHARMACEUTICALS ENGAGES BERRY CONSULTANTS TO ADVISE PHASE 2 TRIAL DESIGN Source text for Eikon: Further company coverage:
Checking out the performance report which defines the increase or decrease of prices for a specific period. For the last 5 trading sessions, its performance is up 0.26% and down -10.44% for month. Its quarterly performance was -42.22% below, while its half year performance is down -56.44%. CNSP performance fall -51.14% for year-to-date. Current recommendation for CNS Pharmaceuticals Inc. is 2.00.
Earnings per share or EPS is an important financial measure, which defines the profitability of a company. CNSP EPS (TTM) for 12-month is -0.38. EPS for this year is 39.60%, while for the next year its value is -0.44. Its EPS Q/Q reached -788.90%.
The insider ownership moved to 60.54% and institutional holding shifted to 0.70%.
The company posted an EPS (TTM) of -0.38. According to the most recent quarter report on Name, CRISPR Therapeutics AG analysts estimated an average EPS of Insperity, Inc., while Consolidated Communications Hol EPS posted a year ago period. Analyst Estimated EPS for CNSP published in the report was $CenterPoint Energy, Inc (Holdin – $Inspire Medical Systems, Inc. during the same period.
A brief look on simple moving average (SMA) that determines the market price can impact a market. The SMA for CNSP fall -40.38% for period of 200 days. SMA for 50 days was -13.98% which is showing red signal, while SMA-20 was 0.82%.